Igm BiosciencesIGMS
13F holders, Q3 2025 (September 30)1holders −65
0new positions
65sold out
$1.27avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Igm Biosciences Inc. (IGMS) in their 13F filings, down 65 from Q2 2025. 0 opened new positions and 65 sold out. The largest holder was Osaic Holdings, Inc. ($508).
- Company
- Igm Biosciences Inc.
- CUSIP
- 449585108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 65 | $17.9M |
All 13F filers, Q2 2025 → Q3 2025: 15,940,578 shares sold, net −15,940,578 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 400 | $508 |
"% of holder's portfolio" is IGMS's weight in each manager's 13F, not the share of Igm Biosciences Inc. the manager owns.